Smith & Nephew SNATS Net Profit Margin 2012-2025 | SNN
Current and historical net profit margin for Smith & Nephew SNATS (SNN) from 2012 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Smith & Nephew SNATS net profit margin for the three months ending June 30, 2025 was .
| Smith & Nephew SNATS Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2014-12-31 | $4.62B | $0.50B | 10.85% |
| 2014-09-30 | $4.54B | $0.50B | 11.07% |
| 2014-06-30 | $4.42B | $0.52B | 11.83% |
| 2014-03-31 | $4.35B | $0.56B | 12.95% |
| 2013-12-31 | $4.35B | $0.56B | 12.78% |
| 2013-09-30 | $4.25B | $0.54B | 12.60% |
| 2013-06-30 | $4.18B | $0.55B | 13.12% |
| 2013-03-31 | $4.13B | $0.71B | 17.20% |
| 2012-12-31 | $4.14B | $0.73B | 17.62% |
| 2012-09-30 | $4.17B | $0.73B | 17.45% |
| 2012-06-30 | $4.25B | $0.73B | 17.10% |
| 2012-03-31 | $4.29B | $0.59B | 13.67% |
| 2011-12-31 | $4.27B | $0.58B | 13.63% |
| 2011-09-30 | $4.23B | $0.62B | 14.75% |
| 2011-06-30 | $4.14B | $0.63B | 15.17% |
| 2011-03-31 | $4.02B | $0.61B | 15.22% |
| 2010-12-31 | $3.96B | $0.62B | 15.52% |
| 2010-09-30 | $3.96B | $0.56B | 14.16% |
| 2010-06-30 | $3.94B | $0.55B | 14.03% |
| 2010-03-31 | $3.90B | $0.53B | 13.66% |
| 2009-12-31 | $3.77B | $0.47B | 12.51% |
| 2009-09-30 | $3.67B | $0.46B | 12.52% |
| 2009-06-30 | $3.68B | $0.41B | 11.00% |
| 2009-03-31 | $3.76B | $0.39B | 10.39% |
| 2008-12-31 | $3.80B | $0.38B | 9.87% |
| 2008-09-30 | $3.81B | $0.36B | 9.48% |
| 2008-06-30 | $3.72B | $0.30B | 8.06% |
| 2008-03-31 | $3.54B | $0.31B | 8.71% |
| 2007-12-31 | $3.37B | $0.32B | 9.38% |
| 2007-09-30 | $3.17B | $0.36B | 11.19% |
| 2007-06-30 | $3.01B | $0.44B | 14.47% |
| 2007-03-31 | $2.88B | $0.42B | 14.72% |
| 2006-12-31 | $2.78B | $0.75B | 27.06% |
| 2006-09-30 | $2.68B | $0.70B | 26.11% |
| 2006-06-30 | $2.61B | $0.67B | 25.62% |
| 2006-03-31 | $2.58B | $0.67B | 25.88% |
| 2005-12-31 | $2.56B | $0.34B | 13.33% |
| 2005-09-30 | $2.59B | $0.26B | 9.93% |
| 2005-06-30 | $2.57B | $0.26B | 10.00% |
| 2005-03-31 | $2.47B | $0.20B | 8.21% |
| 2004-12-31 | $2.40B | $0.18B | 7.62% |
| 2004-09-30 | $2.24B | $0.26B | 11.54% |
| 2004-06-30 | $2.11B | $0.25B | 11.95% |
| 2004-03-31 | $2.04B | $0.27B | 13.38% |
| 2003-12-31 | $1.93B | $0.24B | 12.58% |
| 2003-06-30 | $2.39B | $0.30B | 12.34% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $14.998B | $5.810B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $197.518B | 22.06 |
| EssilorLuxottica (ESLOY) | France | $154.739B | 0.00 |
| Stryker (SYK) | United States | $139.087B | 26.68 |
| Medtronic (MDT) | Ireland | $129.586B | 17.95 |
| Boston Scientific (BSX) | United States | $108.915B | 24.09 |
| Medline (MDLN) | United States | $59.170B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.091B | 0.00 |
| ResMed (RMD) | United States | $37.821B | 25.25 |
| Agilent Technologies (A) | United States | $36.458B | 23.10 |
| GE HealthCare Technologies (GEHC) | United States | $36.095B | 17.29 |
| Koninklijke Philips (PHG) | Netherlands | $30.881B | 18.33 |
| Terumo (TRUMY) | Japan | $20.046B | 22.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.948B | 11.66 |
| Insulet (PODD) | United States | $17.647B | 54.77 |
| Baxter (BAX) | United States | $11.448B | 9.24 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.922B | 28.49 |
| Demant (WILYY) | Denmark | $6.264B | 0.00 |
| Envista Holdings (NVST) | United States | $4.976B | 25.22 |
| Lantheus Holdings (LNTH) | United States | $4.461B | 13.59 |
| BillionToOne (BLLN) | United States | $3.924B | 0.00 |
| ICU Medical (ICUI) | United States | $3.647B | 23.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.122B | 14.73 |
| Haemonetics (HAE) | United States | $2.672B | 11.69 |
| Neogen (NEOG) | United States | $2.338B | 51.19 |
| Phibro Animal Health (PAHC) | United States | $2.088B | 18.40 |
| Perrigo (PRGO) | Ireland | $2.009B | 5.03 |
| LeMaitre Vascular (LMAT) | United States | $1.991B | 40.08 |
| QuidelOrtho (QDEL) | United States | $1.956B | 13.59 |
| Curaleaf Holdings (CURLF) | Canada | $1.649B | 0.00 |
| AtriCure (ATRC) | United States | $1.635B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.625B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.427B | 20.67 |
| Green Thumb Industries (GTBIF) | United States | $1.390B | 60.91 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.304B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.106B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.071B | 317.86 |
| InMode (INMD) | Israel | $0.902B | 9.89 |
| Tilray Brands (TLRY) | Canada | $0.888B | 0.00 |
| Valneva SE (VALN) | France | $0.834B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.798B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.763B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.570B | 13.61 |
| Brainsway (BWAY) | Israel | $0.459B | 78.10 |
| Verano Holdings (VRNO) | United States | $0.432B | 0.00 |
| Cerus (CERS) | United States | $0.413B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.321B | 25.61 |
| Quanterix (QTRX) | United States | $0.279B | 0.00 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.240B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.212B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 18.45 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.195B | 57.33 |
| TerrAscend (TSNDF) | Canada | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.184B | 1.85 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.176B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.174B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.74 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.098B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.24 |
| Exagen (XGN) | United States | $0.075B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 24.96 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 31.08 |
| Cytosorbents (CTSO) | United States | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.40 |
| Jin Medical (ZJYL) | China | $0.025B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |